| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.098 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |